XML 54 R44.htm IDEA: XBRL DOCUMENT v3.22.1
Financial Instruments and Risk Management (Tables)
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Summary of Financial Instruments Measured at Fair Value

The following table represents the fair value amounts of financial assets and financial liabilities measured at estimated fair value on a recurring basis:

 

 

At March 31, 2022

 

At December 31, 2021

 

 

 

Level 1

 

 

Level 2

 

 

 

Level 3

 

 

Level 1

 

 

Level 2

 

 

 

Level 3

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

88,407

 

 

$

-

 

 

 

$

-

 

 

$

79,642

 

 

$

-

 

 

 

$

-

 

Purchase option derivative asset

 

 

 

 

 

 

 

 

 

550

 

 

 

 

 

 

 

 

 

 

868

 

Total Assets

 

$

88,407

 

 

$

-

 

 

 

$

550

 

 

$

79,642

 

 

$

-

 

 

 

$

868

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

 

 

$

-

 

 

 

$

5,700

 

 

$

-

 

 

$

-

 

 

 

$

12,535

 

Warrant liability

 

 

 

 

 

55,021

 

 

 

 

 

 

 

 

 

 

54,986

 

 

 

 

 

Total Liabilities

 

$

-

 

 

$

55,021

 

 

 

$

5,700

 

 

$

-

 

 

$

54,986

 

 

 

$

12,535

 

Summary of Changes in Preferred Share Warrant Liability

The following table summarizes the changes in the warrant liability for the three months ended March 31, 2022:

 

Balance at December 31, 2021

 

$

54,986

 

Addition on acquisition

 

 

6,756

 

Included in gain on fair value of warrants

 

 

(6,031

)

Exercises

 

 

(690

)

Balance at March 31, 2022

 

$

55,021

 

Summary Of Warrant Liability Measured At Fair Value

The warrant liability has been measured at fair value at March 31, 2022. Key inputs and assumptions used in the Black Scholes valuation were as follows:

 

 

 

March 31, 2022

 

 

December 31, 2021

 

Common Stock Price of TerrAscend Corp.

 

$

5.70

 

 

$

6.11

 

Warrant exercise price

 

$

3,000

 

 

$

3,000

 

Warrant conversion ratio

 

$

1,000

 

 

$

1,000

 

Annual volatility

 

 

60.9

%

 

 

65.5

%

Annual risk-free rate

 

 

2.2

%

 

 

0.6

%

Expected term (in years)

 

 

1.2

 

 

1.4

 

Summary of Changes in Purchase Option Derivative Asset

The following table summarizes the changes in the purchase option derivative asset:

 

Balance at December 31, 2021

 

$

868

 

Revaluation of purchase option derivative asset

 

 

(318

)

Balance at March 31, 2022

 

$

550

 

Derivative Asset EBIDTA Assumptions

The purchase option derivative asset has been measured at fair value at the transaction date using the Monte Carlo simulation model that relies on assumptions around the Company's EBITDA volatility and risk adjusted discount, among others. Key inputs and assumptions used in the Monte Carlo simulation model are summarized below:

 

 

 

March 31, 2022

 

 

December 31, 2021

 

Term (in years)

 

 

1.2

 

 

 

1.3

 

Risk-free rate

 

 

1.4

%

 

 

0.4

%

EBITDA discount rate

 

 

15.0

%

 

 

15.0

%

EBITDA volatility

 

 

43.0

%

 

 

44.0

%

Illustrative Variance of Total Contingent Consideration Based on Reasonably Possible Changes To one Significant Unobservable Inputs

The illustrative variance of the total contingent consideration at March 31, 2022 based on reasonably possible changes to one of the significant unobservable inputs, holding other inputs constant, would have the following effects:

 

Discount rate sensitivity

 

KCR

 

Increase 100 basis points

 

$

1,139

 

Increase 50 basis points

 

$

1,160

 

Decrease 50 basis points

 

$

1,203

 

Decrease 100 basis points

 

$

1,225